Jeevan Scientific Technology (BOM:538837) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Jeevan Scientific Technology LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Jeevan Scientific Technology's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.00.

Jeevan Scientific Technology's long-term debt to total assets ratio stayed the same from Dec. 2023 (0.00) to Dec. 2024 (0.00).

Jeevan Scientific Technology LT-Debt-to-Total-Asset Historical Data

The historical data trend for Jeevan Scientific Technology's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeevan Scientific Technology LT-Debt-to-Total-Asset Chart

Jeevan Scientific Technology Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.15

0.12

0.05

0.09

0.14

Jeevan Scientific Technology Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	0.14	-	0.18	-

Jeevan Scientific Technology LT-Debt-to-Total-Asset Calculation

Jeevan Scientific Technology's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )	/	Total Assets (A: Mar. 2024 )
	=	96.185	/	678.656
	=	0.14

Jeevan Scientific Technology's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	0	/	0
	=

Jeevan Scientific Technology (BOM:538837) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Jeevan Scientific Technology LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Jeevan Scientific Technology's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Jeevan Scientific Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jeevan Scientific Technology Ltd (BOM:538837) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot Number 1&2, Sai Krupa Enclave, Manikonda Jagir, Near Lanco Hills, Golconda Post, Hyderabad, TG, IND, 500008

Website

https://www.jeevanscientific.com

Jeevan Scientific Technology Ltd is an India based company engaged in providing Clinical research and data management services. Jeevan Scientific is an Independent Clinical Contract Research Organization, offering reliable, cost-effective, and technology-driven clinical research solutions to various Clients across the globe. Its services offer high-value, advanced testing services, including bioanalytical services for small - large molecules ranging across Generics, Biosimilars, and other new drugs. It operates in a single segment namely Clinical Research Services.

Jeevan Scientific Technology Headlines

No Headlines